MedPath

Comparison of Hydroxyethyl Starch and Crystalloid Coload Combined With Norepinephrine Infusion for Hypotension

Not Applicable
Completed
Conditions
Adverse Effect
Interventions
Drug: Crystalloid
Drug: Hydroxyethyl starch
Registration Number
NCT05475990
Lead Sponsor
General Hospital of Ningxia Medical University
Brief Summary

The purpose of this study is to investigate the ED50 and ED90 for an effective 6% Hydroxyethyl starch (130/0.4) or crystalloid coload combined with prophylactic norepinephrine infusion dose for postspinal anesthesia hypotension in patients undergoing cesarean section.

Detailed Description

Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for cesarean section. The incidence of post-spinal anesthesia hypotension is as high as 62.1-89.7% if prophylactic measures are not taken. Colloid fluid coload has been highly demonstrated for prevention and/or treatment of post-spinal anesthesia hypotension. In addition, there's some evidence that prophylactic infusion of norepinephrine could effectively reduce the incidence of post-spinal anesthesia hypotension in parturients undergoing cesarean section. However, the ED50 and ED90 for an effective 6% Hydroxyethyl starch (130/0.4) or crystalloid coload combined with prophylactic norepinephrine infusion dose for postspinal anesthesia hypotension is still unknown. The purpose of this study is to investigate the ED50 and ED90 for an effective 6% Hydroxyethyl starch (130/0.4) or crystalloid coload combined with prophylactic norepinephrine infusion dose for postspinal anesthesia hypotension in patients undergoing cesarean section.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • 18-40 years
  • Primipara or multipara
  • Singleton pregnancy ≥ 37 weeks
  • American Society of Anesthesiologists physical status classification I to II
  • Scheduled for elective cesarean section under spinal anesthesia
Read More
Exclusion Criteria
  • Body height < 150 cm
  • Body weight > 100 kg or body mass index (BMI) ≥ 40 kg/m2
  • Eclampsia or chronic hypertension or baseline blood pressure ≥ 160mmHg
  • Hemoglobin < 7g/dl
  • Coagulation or renal function disorders
  • Known allergy to hydroxyethyl starch
  • Fetal distress, or known fetal developmental anomaly
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Crystalloid coload groupCrystalloid10 ml/kg crystalloid coload combined with an initial infusion dose of prophylactic norepinephrine simultaneous with spinal anesthesia.
Hydroxyethyl starch coload groupHydroxyethyl starch10 ml/kg 6% Hydroxyethyl starch (130/0.4) coload combined with an initial infusion dose of prophylactic norepinephrine simultaneous with spinal anesthesia
Primary Outcome Measures
NameTimeMethod
ED 50 and ED 901-15 minutes after spinal anesthesia

The dose of prophylactic norepinephrine combined with 10 ml/kg 6% Hydroxyethyl starch (130/0.4) or 10 ml/kg crystalloid coload that would be effective in preventing postspinal anesthesia hypotension in 50% (effective dose, ED 50) and 90% (ED90) of patients

Secondary Outcome Measures
NameTimeMethod
The incidence of bradycardia.1-15 minutes after spinal anesthesia

Heart rate \< 60 beats/min.

The incidence of post-spinal anesthesia hypotension1-15 minutes after spinal anesthesia

Systolic blood pressure (SBP) \< 80% of the baseline

The incidence of severe post-spinal anesthesia hypotension.1-15 minutes after spinal anesthesia

Systolic blood pressure (SBP) \< 60% of the baseline.

The incidence of nausea and vomiting.1-15 minutes after spinal anesthesia

Presence of nausea and vomiting in patients after spinal anesthesia

pHImmediately after delivery

From umbilical arterial blood gases.

Partial pressure of oxygen (PO2)Immediately after delivery

From umbilical arterial blood gases.

The incidence of hypertension.1-15 minutes after spinal anesthesia

Systolic blood pressure (SBP) \>120% of the baseline.

Base excess (BE)Immediately after delivery

From umbilical arterial blood gases.

APGAR score5 min after delivery

A= Appearance P=Pulse G=Grimace A=Attitude R=Respiration

Trial Locations

Locations (1)

General Hospital of Ningxia Medical University

🇨🇳

Yinchuan, Ningxia, China

© Copyright 2025. All Rights Reserved by MedPath